PCSK9 Inhibitors and Neurocognitive Adverse Drug Reactions: Analysis of Individual Case Safety Reports from the Eudravigilance Database

Meningitis

drug-induced aseptic meningitis: 329 cases from the French Pharmacovigilance Database Analysis

Br J Clin Pharmacol.

Bihan K, Weiss N, Théophile H, Funck-Brentano C, Lebrun-Vignes B

doi: 10.1111/bcp.14073.

Viral Infections, Non-HIV

Amid COVID-19: the importance of developing an positive adverse drug reaction (ADR) and medical device incident (MDI) reporting culture for Global Health and public safety

J Pharm Policy Pract.

Elbeddini A, Yeats A, Lee S

doi: 10.1186/s40545-020-00219-1.

Pain Management

Drug safety and adverse drug reaction reporting behavior related to outpatient opioid replacement therapy: Results from a survey among physicians

J Subst Abuse Treat.

Gahr M, Eller J, Cabanis M, Hiemke C, Freudenmann RW, Connemann BJ, Lang D, Schönfeldt-Lecuona C

doi: 10.1016/j.jsat.2016.12.002.

Further Publications Anesthesiology

Retrospective analysis of adverse drug reactions leading to short-term emergency hospital readmission

Swiss Med Wkly

Banholzer S, Dunkelmann L, Haschke M, Derungs A, Exadaktylos A, Krähenbühl S, Liakoni E

doi: 10.4414/smw.2021.20400

Viral Infections, Non-HIV

Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre-COVID-19 reports

Br J Clin Pharmacol.

Goldman A, Bomze D, Dankner R, Hod H, Meirson T, Boursi B, Maor E

doi: 10.1111/bcp.14546.

Further Publications Infectiology

A Network Analysis of Drug Combinations Associated with Acute Generalized Exanthematous Pustulosis (AGEP)

J Clin Med

Martinez-De la Torre A, van Weenen E, Kraus M, Weiler S, Feuerriegel S, Burden AM

doi: 10.3390/jcm10194486

HIV / AIDS

Safety, pharmacokinetics, and antiretroviral activity of islatravir (ISL, MK-8591), a novel nucleoside reverse transcriptase translocation inhibitor, following single-dose administration to treatment-naive adults infected with HIV-1: an open-label, phase 1b, consecutive-panel trial

Lancet HIV.

Schürmann D, Rudd DJ, Zhang S, De Lepeleire I, Robberechts M, Friedman E, Keicher C, Hüser A, Hofmann J, Grobler JA, Stoch SA, Iwamoto M, Matthews RP

doi: 10.1016/S2352-3018(19)30372-8.

Viral Infections, Non-HIV

Adverse events following quadrivalent meningococcal diphtheria toxoid conjugate vaccine (Menactra®) reported to the Vaccine Adverse Event Reporting System (VAERS), 2005-2016

Vaccine

Myers TR, McNeil MM, Ng CS, Li R, Marquez PL, Moro PL, Omer SB, Cano MV

doi: 10.1016/j.vaccine.2020.07.039

Viral Infections, Non-HIV

Adverse events following quadrivalent meningococcal diphtheria toxoid conjugate vaccine (Menactra®) reported to the Vaccine Adverse Event Reporting System (VAERS), 2005-2016

Vaccine.

Myers TR, McNeil MM, Ng CS, Li R, Marquez PL, Moro PL, Omer SB, Cano MV

doi: 10.1016/j.vaccine.

Related content

drug-induced aseptic meningitis: 329 cases from the French Pharmacovigilance Database Analysis

Amid COVID-19: the importance of developing an positive adverse drug reaction (ADR) and medical device incident (MDI) reporting culture for Global Health and public safety

Drug safety and adverse drug reaction reporting behavior related to outpatient opioid replacement therapy: Results from a survey among physicians

Retrospective analysis of adverse drug reactions leading to short-term emergency hospital readmission

Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre-COVID-19 reports

A Network Analysis of Drug Combinations Associated with Acute Generalized Exanthematous Pustulosis (AGEP)

Safety, pharmacokinetics, and antiretroviral activity of islatravir (ISL, MK-8591), a novel nucleoside reverse transcriptase translocation inhibitor, following single-dose administration to treatment-naive adults infected with HIV-1: an open-label, phase 1b, consecutive-panel trial

Adverse events following quadrivalent meningococcal diphtheria toxoid conjugate vaccine (Menactra®) reported to the Vaccine Adverse Event Reporting System (VAERS), 2005-2016

Adverse events following quadrivalent meningococcal diphtheria toxoid conjugate vaccine (Menactra®) reported to the Vaccine Adverse Event Reporting System (VAERS), 2005-2016